Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein

The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental parasitology 1995-09, Vol.81 (2), p.216-226
Hauptverfasser: Moore, D.R., Smith, A., Hager, K.M., Waldon, R., Esko, J.D., Hajduk, S.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 226
container_issue 2
container_start_page 216
container_title Experimental parasitology
container_volume 81
creator Moore, D.R.
Smith, A.
Hager, K.M.
Waldon, R.
Esko, J.D.
Hajduk, S.L.
description The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.
doi_str_mv 10.1006/expr.1995.1111
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17002776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489485711113</els_id><sourcerecordid>17002776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-bee4566459d448ca22198737af617588915f1804bb9bbf7355088040b96b8fb23</originalsourceid><addsrcrecordid>eNp1kEGP1CAYhhujWcfVqwcTkx7M3jpCBygczeyuYzKJibt7JkA_ZjFtqUAn24P_XeqMe5PLF_I-vMBTFO8xWmOE2Gd4GsMaC0HXOK8XxQojgaqaEPGyWCGESUW4IK-LNzH-RAhxXJOL4qKhlFFGVsXvazhC58cehqS6bi5_wGHqVIK2vIMhuuSOLs2lt-V9mEc1-Oh7VeowGXD_RvJleoRyOyef_JMz5Y21YFJcTu2mXg3lzh0eq-u_fXO5d6Mfg0_ghrfFK6u6CO_O87J4uL253-6q_fev37Zf9pUhmKdKAxDKGKGiJYQbVddY8GbTKMtwQzkXmFrMEdFaaG2bDaWI5y3Sgmludb25LK5OvfneXxPEJHsXDXSdGsBPUeIGobppWAbXJ9AEH2MAK8fgehVmiZFcfMvFt1x8y8V3PvDx3DzpHtpn_Cw455_OuYpGdTaowbj4jG1YQzdsqflwwqzyUh1CRh7uRP4zJSKH_BRCVnR0EGQ0DgYDrQvZs2y9-9_z_gA8tqWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17002776</pqid></control><display><type>article</type><title>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Moore, D.R. ; Smith, A. ; Hager, K.M. ; Waldon, R. ; Esko, J.D. ; Hajduk, S.L.</creator><creatorcontrib>Moore, D.R. ; Smith, A. ; Hager, K.M. ; Waldon, R. ; Esko, J.D. ; Hajduk, S.L.</creatorcontrib><description>The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1006/expr.1995.1111</identifier><identifier>PMID: 7556564</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>ANIMAL DEVELOPMENTAL STAGES ; Animals ; Biological and medical sciences ; Biological Transport ; BLOOD SERUM ; Cell Differentiation ; CYTOTOXICITY ; Cytotoxins ; Drug Resistance ; Endocytosis ; ETAPAS DEL DESARROLLO ANIMAL ; Experimental protozoal diseases and models ; Female ; Fluorescent Antibody Technique ; GENERO HUMANO ; GENRE HUMAIN ; Humans ; Infectious diseases ; LIPOPROTEINAS ; LIPOPROTEINE ; LIPOPROTEINS ; Lipoproteins, HDL - metabolism ; Lipoproteins, HDL - pharmacology ; MANKIND ; Medical sciences ; Parasitic diseases ; PROCYCLIC TRYPANOSOMES ; Protein Binding ; Protozoal diseases ; Protozoan Proteins - biosynthesis ; Rats ; RESISTANCE ; SERUM SANGUIN ; STADE DE DEVELOPPEMENT ANIMAL ; SUERO SANGUINEO ; SUSCEPTIBILITY ; TOXICIDAD ; TOXICITE ; TOXICITY ; Toxicity Tests ; Trypanocidal Agents - blood ; Trypanocidal Agents - metabolism ; Trypanocidal Agents - pharmacology ; TRYPANOSOMA BRUCEI ; Trypanosoma brucei brucei ; Trypanosoma brucei brucei - drug effects ; Trypanosoma brucei brucei - growth &amp; development ; Trypanosoma brucei brucei - ultrastructure ; TRYPANOSOME LYTIC FACTOR ; Variant Surface Glycoproteins, Trypanosoma - analysis</subject><ispartof>Experimental parasitology, 1995-09, Vol.81 (2), p.216-226</ispartof><rights>1995 Academic Press</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-bee4566459d448ca22198737af617588915f1804bb9bbf7355088040b96b8fb23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/expr.1995.1111$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3675361$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7556564$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, D.R.</creatorcontrib><creatorcontrib>Smith, A.</creatorcontrib><creatorcontrib>Hager, K.M.</creatorcontrib><creatorcontrib>Waldon, R.</creatorcontrib><creatorcontrib>Esko, J.D.</creatorcontrib><creatorcontrib>Hajduk, S.L.</creatorcontrib><title>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.</description><subject>ANIMAL DEVELOPMENTAL STAGES</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biological Transport</subject><subject>BLOOD SERUM</subject><subject>Cell Differentiation</subject><subject>CYTOTOXICITY</subject><subject>Cytotoxins</subject><subject>Drug Resistance</subject><subject>Endocytosis</subject><subject>ETAPAS DEL DESARROLLO ANIMAL</subject><subject>Experimental protozoal diseases and models</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>GENERO HUMANO</subject><subject>GENRE HUMAIN</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>LIPOPROTEINAS</subject><subject>LIPOPROTEINE</subject><subject>LIPOPROTEINS</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Lipoproteins, HDL - pharmacology</subject><subject>MANKIND</subject><subject>Medical sciences</subject><subject>Parasitic diseases</subject><subject>PROCYCLIC TRYPANOSOMES</subject><subject>Protein Binding</subject><subject>Protozoal diseases</subject><subject>Protozoan Proteins - biosynthesis</subject><subject>Rats</subject><subject>RESISTANCE</subject><subject>SERUM SANGUIN</subject><subject>STADE DE DEVELOPPEMENT ANIMAL</subject><subject>SUERO SANGUINEO</subject><subject>SUSCEPTIBILITY</subject><subject>TOXICIDAD</subject><subject>TOXICITE</subject><subject>TOXICITY</subject><subject>Toxicity Tests</subject><subject>Trypanocidal Agents - blood</subject><subject>Trypanocidal Agents - metabolism</subject><subject>Trypanocidal Agents - pharmacology</subject><subject>TRYPANOSOMA BRUCEI</subject><subject>Trypanosoma brucei brucei</subject><subject>Trypanosoma brucei brucei - drug effects</subject><subject>Trypanosoma brucei brucei - growth &amp; development</subject><subject>Trypanosoma brucei brucei - ultrastructure</subject><subject>TRYPANOSOME LYTIC FACTOR</subject><subject>Variant Surface Glycoproteins, Trypanosoma - analysis</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEGP1CAYhhujWcfVqwcTkx7M3jpCBygczeyuYzKJibt7JkA_ZjFtqUAn24P_XeqMe5PLF_I-vMBTFO8xWmOE2Gd4GsMaC0HXOK8XxQojgaqaEPGyWCGESUW4IK-LNzH-RAhxXJOL4qKhlFFGVsXvazhC58cehqS6bi5_wGHqVIK2vIMhuuSOLs2lt-V9mEc1-Oh7VeowGXD_RvJleoRyOyef_JMz5Y21YFJcTu2mXg3lzh0eq-u_fXO5d6Mfg0_ghrfFK6u6CO_O87J4uL253-6q_fev37Zf9pUhmKdKAxDKGKGiJYQbVddY8GbTKMtwQzkXmFrMEdFaaG2bDaWI5y3Sgmludb25LK5OvfneXxPEJHsXDXSdGsBPUeIGobppWAbXJ9AEH2MAK8fgehVmiZFcfMvFt1x8y8V3PvDx3DzpHtpn_Cw455_OuYpGdTaowbj4jG1YQzdsqflwwqzyUh1CRh7uRP4zJSKH_BRCVnR0EGQ0DgYDrQvZs2y9-9_z_gA8tqWQ</recordid><startdate>19950901</startdate><enddate>19950901</enddate><creator>Moore, D.R.</creator><creator>Smith, A.</creator><creator>Hager, K.M.</creator><creator>Waldon, R.</creator><creator>Esko, J.D.</creator><creator>Hajduk, S.L.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope></search><sort><creationdate>19950901</creationdate><title>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</title><author>Moore, D.R. ; Smith, A. ; Hager, K.M. ; Waldon, R. ; Esko, J.D. ; Hajduk, S.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-bee4566459d448ca22198737af617588915f1804bb9bbf7355088040b96b8fb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>ANIMAL DEVELOPMENTAL STAGES</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biological Transport</topic><topic>BLOOD SERUM</topic><topic>Cell Differentiation</topic><topic>CYTOTOXICITY</topic><topic>Cytotoxins</topic><topic>Drug Resistance</topic><topic>Endocytosis</topic><topic>ETAPAS DEL DESARROLLO ANIMAL</topic><topic>Experimental protozoal diseases and models</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>GENERO HUMANO</topic><topic>GENRE HUMAIN</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>LIPOPROTEINAS</topic><topic>LIPOPROTEINE</topic><topic>LIPOPROTEINS</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Lipoproteins, HDL - pharmacology</topic><topic>MANKIND</topic><topic>Medical sciences</topic><topic>Parasitic diseases</topic><topic>PROCYCLIC TRYPANOSOMES</topic><topic>Protein Binding</topic><topic>Protozoal diseases</topic><topic>Protozoan Proteins - biosynthesis</topic><topic>Rats</topic><topic>RESISTANCE</topic><topic>SERUM SANGUIN</topic><topic>STADE DE DEVELOPPEMENT ANIMAL</topic><topic>SUERO SANGUINEO</topic><topic>SUSCEPTIBILITY</topic><topic>TOXICIDAD</topic><topic>TOXICITE</topic><topic>TOXICITY</topic><topic>Toxicity Tests</topic><topic>Trypanocidal Agents - blood</topic><topic>Trypanocidal Agents - metabolism</topic><topic>Trypanocidal Agents - pharmacology</topic><topic>TRYPANOSOMA BRUCEI</topic><topic>Trypanosoma brucei brucei</topic><topic>Trypanosoma brucei brucei - drug effects</topic><topic>Trypanosoma brucei brucei - growth &amp; development</topic><topic>Trypanosoma brucei brucei - ultrastructure</topic><topic>TRYPANOSOME LYTIC FACTOR</topic><topic>Variant Surface Glycoproteins, Trypanosoma - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, D.R.</creatorcontrib><creatorcontrib>Smith, A.</creatorcontrib><creatorcontrib>Hager, K.M.</creatorcontrib><creatorcontrib>Waldon, R.</creatorcontrib><creatorcontrib>Esko, J.D.</creatorcontrib><creatorcontrib>Hajduk, S.L.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, D.R.</au><au>Smith, A.</au><au>Hager, K.M.</au><au>Waldon, R.</au><au>Esko, J.D.</au><au>Hajduk, S.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>1995-09-01</date><risdate>1995</risdate><volume>81</volume><issue>2</issue><spage>216</spage><epage>226</epage><pages>216-226</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>7556564</pmid><doi>10.1006/expr.1995.1111</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4894
ispartof Experimental parasitology, 1995-09, Vol.81 (2), p.216-226
issn 0014-4894
1090-2449
language eng
recordid cdi_proquest_miscellaneous_17002776
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects ANIMAL DEVELOPMENTAL STAGES
Animals
Biological and medical sciences
Biological Transport
BLOOD SERUM
Cell Differentiation
CYTOTOXICITY
Cytotoxins
Drug Resistance
Endocytosis
ETAPAS DEL DESARROLLO ANIMAL
Experimental protozoal diseases and models
Female
Fluorescent Antibody Technique
GENERO HUMANO
GENRE HUMAIN
Humans
Infectious diseases
LIPOPROTEINAS
LIPOPROTEINE
LIPOPROTEINS
Lipoproteins, HDL - metabolism
Lipoproteins, HDL - pharmacology
MANKIND
Medical sciences
Parasitic diseases
PROCYCLIC TRYPANOSOMES
Protein Binding
Protozoal diseases
Protozoan Proteins - biosynthesis
Rats
RESISTANCE
SERUM SANGUIN
STADE DE DEVELOPPEMENT ANIMAL
SUERO SANGUINEO
SUSCEPTIBILITY
TOXICIDAD
TOXICITE
TOXICITY
Toxicity Tests
Trypanocidal Agents - blood
Trypanocidal Agents - metabolism
Trypanocidal Agents - pharmacology
TRYPANOSOMA BRUCEI
Trypanosoma brucei brucei
Trypanosoma brucei brucei - drug effects
Trypanosoma brucei brucei - growth & development
Trypanosoma brucei brucei - ultrastructure
TRYPANOSOME LYTIC FACTOR
Variant Surface Glycoproteins, Trypanosoma - analysis
title Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T20%3A27%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developmentally%20Regulated%20Sensitivity%20of%20Trypanosoma%20brucei%20brucei%20to%20the%20Cytotoxic%20Effects%20of%20Human%20High-Density%20Lipoprotein&rft.jtitle=Experimental%20parasitology&rft.au=Moore,%20D.R.&rft.date=1995-09-01&rft.volume=81&rft.issue=2&rft.spage=216&rft.epage=226&rft.pages=216-226&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1006/expr.1995.1111&rft_dat=%3Cproquest_cross%3E17002776%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17002776&rft_id=info:pmid/7556564&rft_els_id=S0014489485711113&rfr_iscdi=true